Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 459
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 113
Clinical Trials 107
Central Nervous System Drugs 106
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 95
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 35
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
HIV/AIDS Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

2,424 Results (Page 45 of 122)
- Relevance
  Sort by

Europe Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Range, Route of Administration, Indication, and Distribution Channel

 Report
September 2022
73 Pages
Europe

From

€3073EUR$3,450USD£2,658GBP

Psoriasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
January 2023
1469 Pages
Global

From

€4453EUR$5,000USD£3,852GBP

Ethical Pharmaceutical Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
102 Pages
Global

From

€3500EUR$4,210USD£3,133GBP

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis)

 Report
November 2022
57 Pages
Global

€9573EUR$11,124USD£8,000GBP

Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
643 Pages
Global

From

€2227EUR$2,500USD£1,926GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pancreatic Cancer Treatment - Global Strategic Business Report

 Report
August 2025
381 Pages
Global

From

€5210EUR$5,850USD£4,507GBP

Entecavir Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
84 Pages
Global

From

€3500EUR$4,210USD£3,133GBP

Communicable Diseases Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
96 Pages
Global

From

€3500EUR$4,210USD£3,133GBP

Biliary Tract Cancers - Global Strategic Business Report

 Report
August 2025
282 Pages
Global

From

€5210EUR$5,850USD£4,507GBP

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups

 Report
November 2022
54 Pages
Global

€6731EUR$7,821USD£5,625GBP

Oral Anti-diabetes Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

 Report
August 2020
150 Pages
Global

From

€3785EUR$4,250USD£3,274GBP

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

 Report
October 2022
58 Pages
Global

€9573EUR$11,124USD£8,000GBP

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups

 Report
September 2022
559 Pages
Spain

€9573EUR$11,124USD£8,000GBP

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups

 Report
September 2022
59 Pages
Italy

€9573EUR$11,124USD£8,000GBP

Monoclonal antibodies - Competitive landscape, 2023

 Report
May 2023
450 Pages
Global

From

€4453EUR$5,000USD£3,852GBP

2024 Succeeding in the Pharmaceutical Market: Supplier Strategies and Capabilities

 Report
January 2024
Global

From

€3117EUR$3,500USD£2,696GBP

Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
115 Pages
Global

From

€4231EUR$4,750USD£3,659GBP

Anti-Viral Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
97 Pages
Global

From

€3500EUR$4,210USD£3,133GBP

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

 Report
August 2022
59 Pages
Germany

€9573EUR$11,124USD£8,000GBP

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

 Report
August 2022
58 Pages
Asia Pacific

€9573EUR$11,124USD£8,000GBP

2,424 Results (Page 45 of 122)
- 1
- 43
- 44
- 45
- 46
- 47

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.